medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2026, Number S1

<< Back Next >>

Rev Mex Med Transfus 2026; 18 (S1)

Impacto de los nuevos descubrimientos de grupos sanguíneos en el diagnóstico y la terapia transfusional

Castilho L

Language: Spanish
References: 4
Page: s80-s81
PDF size: 121.93 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Hyland CA, Castilho L, Chen Q, Clausen FB, Denomme GA, FichouY et al. International Society of Blood Transfusion Working Party onRed Cell Immunogenetics and Blood Group Terminology Reportof Gothenburg, Barcelona and four virtual business meetings:Update on blood group systems. Vox Sang. 2026; 121 (2): 202-212.

  2. Hawksworth J, Satchwell TJ, Meinders M, Daniels DE, Regan F etal. Enhancement of red blood cell transfusion compatibility usingCRISPR-mediated erythroblast gene editing. EMBO Mol Med. 2018;10: e8454.

  3. Boccacci Y, Dumont N, Doyon Y, Laganiere J. CRISPR-Cas9-drivenantigen conversion of clinically relevant blood group systems.Hum Mol Genet. 2025; 34 (12): 1001-1008.

  4. Rousseau GF, Rasschaert F, Maestrali M, Lardier G, Mathieu F,Giarratana MC et al. Industrial production of red blood cells fromstem cells: a vision finally within reach. Blood. 2022; 140 (Suppl 1):4691-4692. doi: 10.1182/blood-2022-158186.




2020     |     www.medigraphic.com